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Abstract
Purpose Our aim was to evaluate the resolution of negative
dysphotopsia after supplementary implantation of a sulcus-
fixated intraocular lens (IOL).
Methods This was a retrospective case series. Patients with
severe negative dysphotopsia were treated with supplementa-
ry implantation of the Rayner Sulcoflex Aspheric (653 L)
IOL. Primary outcome measurements were subjectively re-
ported complaints of dysphotopsia, best corrected distance
visual acuity (CDVA), iris-IOL distance, anterior chamber
depth (ACD) and volume (ACV), angle opening distance
and trabecular-iris space area at 500 and 750 μm.
Results A Rayner Sulcoflex IOL was implanted in seven pa-
tients (nine eyes) with negative dysphotopsias. Symptoms re-
solved completely in six eyes, partially in one eye and
remained unchanged in two eyes. We did not find any signif-
icant changes in CDVA. Angle opening distance, ACD, ACV
and iris-IOL distance reduced significantly after Sulcoflex
IOL implantation.
Conclusions Supplementary implantation of a Sulcoflex IOL
can successfully treat negative dysphotopsia. The decrease in
anterior segment dimensions in combination with the dis-
placement of light rays by the rounded edges of a Sulcoflex
IOL may contribute to the resolution of symptoms.
Keywords Negative dysphotopsia . Pseudophakia/
complications . Sulcus-fixated intraocular lens
Introduction
Unwanted optical phenomena such as negative and positive
dysphotopsias are well known side effects after cataract sur-
gery [1]. Negative dysphotopsia is defined as the perception of
a shadow obscuring the temporal field of vision, while posi-
tive dysphotopsia is characterised by halos, arcs or streaks
around point light sources [2, 3].
In the majority of cases, dysphotopsias resolve or diminish
over time. Therefore Bwatchful waiting^ and reassurance are
reasonable initial treatment strategies. However, in 0.2 to 1 %
of pseudophakic patients severe symptoms will persist [2, 4]
and additional surgery may be required.
Implantation of a secondary intraocular lens (IOL) has
been proposed as an option to alleviate negative
dysphotopsias [5, 6]. Partial or complete resolution of
symptoms has been reported after supplementary implanta-
tion of a Sulcoflex 653 L IOL (Rayner Intraocular Lenses
Ltd, East Sussex, UK) in one eye [6], AQ5010V IOLs
(STAAR Surgical Company, Monrovia, CA) in six eyes
[5] and a Clariflex IOL (Abbott Medical Optics Inc.,
Santa Ana, CA) in one eye [5]. In this study, we report a
case series of patients with severe negative dysphotopsias
who were treated with supplementary implantation of a
Sulcoflex IOL.
Materials and methods
Files of patients with negative dysphotopsias who underwent
supplementary implantation of a Sulcoflex IOL were
reviewed retrospectively. In our hospital all clinical data may
be used for research, unless a patient has given a written ob-
jection. Further, local medical ethical committee requires no
approval for retrospective studies.
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All patients underwent uneventful phacoemulsification
with IOL implantation in the capsular bag. Secondary implan-
tations were performed by two experienced surgeons (R.N.
and H.B.) at the University Eye Clinic in Maastricht. A pe-
ripheral iridotomy was made to prevent postoperative intraoc-
ular pressure (IOP) spikes. A Sulcoflex Aspheric (653 L) IOL
with powers varying from −0.5 to 0.5D was used in all cases
and placed in the ciliary sulcus (Fig. 1). Complaints of
dysphotopsia were noted before surgery and at each follow-
up visit. Evaluation included uncorrected (UDVA) and
corrected (CDVA) distance visual acuity, manifest refraction,
Goldman applanation tonometry, slit-lamp examination,
Scheimpflug photography (Pentacam, Oculus Optikgeräte
GmbH, Wetzlar, Germany) and anterior segment optical co-
herence tomography (Visante, Carl Zeiss Meditec, Inc,
Dublin, CA and Casia, SS-1000, Tomey Corporation,
Nagoya, Japan).
Results
A Sulcoflex IOL was implanted in seven patients (nine eyes)
with negative dysphotopsias (Table 1). Two patients also had
positive dysphotopsias. The mean age of the patients was 63.0
±6.6 years. Negative dysphotopsias resolved completely in
six eyes, partially in one eye and remained unchanged in
two eyes.
There was no significant change in CDVA, spherical equiv-
alent refraction (SE) and IOP after surgery (Table 2). Anterior
chamber depth (ACD) and volumewere significantly reduced.
All iridocorneal angle measurements were reduced, and this
was significant for angle opening distances at 500 and
750 μm. Implantation of the supplementary IOLs caused a
small posterior movement of the primary IOLs, as the distance
between the posterior corneal surface and the primary IOL
increased significantly by 2 % (range 0 to 3 %).
Explantation of the Sulcoflex IOL was performed in one
patient (case 6) who reported increased positive and un-
changed negative dysphotopsia after surgery. After
Fig. 1 A slit-lamp photograph of a supplementary IOL: a cross-sectional
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explantation of the Sulcoflex IOL, symptoms returned to the
preoperative level. In one patient (case 4), a small anterior
chamber hemorrhage occurred after peripheral iridotomy. No
other complications, e.g., iris chafing, inflammation or IOP
elevation occurred during follow-up.
Discussion
The current treatment options for severe persistent negative
dysphotopsia are IOL exchange with placement of a second-
ary IOL in the bag or in the ciliary sulcus, implantation of a
supplementary IOL, reverse optic capture and Nd: YAG ante-
rior capsulectomy; however, in some cases the symptomsmay
persist after treatment [2, 4–12]. We have shown that supple-
mentary implantation of a Sulcoflex IOL can successfully
treat negative dysphotopsias. Because of the complexity of
dysphotopsia pathogenesis, in several cases symptoms may
persist or only partially resolve. Negative dysphotopsia occurs
with IOLs of different materials [2, 5, 10, 11] with both round-
ed and squared edges [2, 10, 13]. All our patients had acrylic
IOLs with 6.0 mm optics and squared or frosted edges.
Davison suggested that some patients might develop
an unique interaction between the optical pathways of
the eye and the IOL [4]. One possible mechanism is the
reflection of light rays between the IOL edges and the
anterior capsulorhexis, which can be successfully treated
with anterior Nd:YAG capsulectomy, reverse optic cap-
ture, or by covering of the anterior capsulorhexis with a sulcus
IOL [5, 8, 9].
A large distance between the anterior surface of the IOL
and the posterior iris surface may also play a role [3, 14], as the
reduction of this distance by implantation of an IOL in the
sulcus can eliminate the symptoms [15]. This distance was
reduced in all our cases; however, in two cases
dysphotopsia did not improve. Persistence of dysphotopsia
in cases with a shallow posterior chamber were also reported
by Masket et al. [5].
Table 2 Preoperative and postoperative patient characteristics
Mean±SD Preoperative Postoperative p-value
(paired samples T-test)
CDVA, log MARa −0.02±0.04 −0.05±0.08 0.39
SE, D 0.13±0.23 −0.00±0.36 0.43
IOP, mm Hg 12.3±1.8 13.3±2.5 0.24
AS-OCT (7 eyes)
AOD 500, mm
Nasal 0.60±0.20 0.50±0.17 < 0.05
Temporal 0.64±0.21 0.51±0.17 < 0.05
AOD 750, mm
Nasal 0.91±0.23 0.77±0.18 < 0.01
Temporal 0.97±0.32 0.80±0.25 < 0.05
TISA 500, mm
Nasal 0.22±0.06 0.19±0.07 0.07
Temporal 0.22±0.07 0.18±0.07 0.24
TISA 750, mm
Nasal 0.41±0.12 0.35±0.11 0.07
Temporal 0.42±0.14 0.34±0.12 0.05
Iris-IOL distance, mm 0.61±0.11 0.01±0.02 < 0.01
ACD, mm 4.16±0.36 3.20±0.28 < 0.01
Cornea-IOL distance, mmb 0.56±0.11 0.47±0.02 < 0.05
Scheimpflug photography (8 eyes)
ACD, mm 4.37±0.48 3.13±0.23 < 0.01
ACV, mm3 176±28 154±25 < 0.01
ACD anterior chamber depth; ACVanterior chamber volume; AOD angle opening distance;CDVA best corrected distance visual acuity; AS-OCTanterior
segment optical coherence tomography; D diopter; IOL intraocular lens; SE spherical equivalent (Sphere+1/2 Cylinder); SD standard deviation; TISA
trabecular iris space area
a One eye with late AMD and CDVA of 20/2000 before Sulcoflex implantation and CDVA 20/400 after surgery was excluded from analysis
b Distance between the posterior corneal surface and the primary IOL
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The dimensions of the anterior chamber were reduced after
secondary surgery (Fig. 2a and b). Increase in the ACD and
iridocorneal angle after phacoemulsification may possibly
contribute to the development of negative dysphotopsia, and
therefore reduction of these parameters by Sulcoflex IOL im-
plantation may be a good strategy. However, the retrospective
character of our study does not allow us to establish any causal
relationships.
We have found minor posterior movement of the pri-
mary IOL which did not cause any significant change in
SE, and none of the patients lost more than two lines of
CDVA. A supplementary IOL was removed without any
complications in a patient, who was dissatisfied with the
outcome.
In conclusion, supplementary implantation of the
Sulcoflex IOL is a safe and effective treatment of per-
sistent negative dysphotopsia. A Sulcoflex IOL reduces
the dimensions of the anterior and posterior chambers,
covers the anterior capsulorhexis, and may refract or
reflect light rays by its surfaces and rounded edges.
All these mechanisms may reduce the intensity of the photic
images on the retina and contribute to the development of
neuroadaptation.
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